Group One Trading’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $166K | Sell |
25,856
-17,378
| -40% | -$111K | ﹤0.01% | 960 |
|
|
2025
Q1 | $153K | Sell |
43,234
-6,665
| -13% | -$23.6K | ﹤0.01% | 881 |
|
|
2024
Q4 | $189K | Sell |
49,899
-79,391
| -61% | -$300K | ﹤0.01% | 898 |
|
|
2024
Q3 | $419K | Sell |
129,290
-159,991
| -55% | -$518K | ﹤0.01% | 539 |
|
|
2024
Q2 | $550K | Buy |
289,281
+66,559
| +30% | +$126K | ﹤0.01% | 450 |
|
|
2024
Q1 | $633K | Sell |
222,722
-280,950
| -56% | -$798K | ﹤0.01% | 425 |
|
|
2023
Q4 | $7.41M | Buy |
503,672
+466,301
| +1,248% | +$6.86M | 0.02% | 96 |
|
|
2023
Q3 | $684K | Buy |
37,371
+35,489
| +1,886% | +$650K | ﹤0.01% | 454 |
|
|
2023
Q2 | $40.6K | Sell |
1,882
-1,720
| -48% | -$37.1K | ﹤0.01% | 1057 |
|
|
2023
Q1 | $106K | Sell |
3,602
-21,936
| -86% | -$644K | ﹤0.01% | 851 |
|
|
2022
Q4 | $944K | Sell |
25,538
-63,447
| -71% | -$2.34M | ﹤0.01% | 386 |
|
|
2022
Q3 | $2.51M | Sell |
88,985
-66,403
| -43% | -$1.87M | ﹤0.01% | 216 |
|
|
2022
Q2 | $2.99M | Buy |
155,388
+154,145
| +12,401% | +$2.97M | ﹤0.01% | 233 |
|
|
2022
Q1 | $16K | Buy |
+1,243
| New | +$16K | ﹤0.01% | 1680 |
|